Primary asphyxiating thoracic dystrophy, also known as Jeune syndrome, is a rare autosomal recessive genetic disorder linked to pathogenic gene variants. Although its detailed pathogenesis remains incompletely understood, the resulting thoracic abnormalities can cause serious respiratory problems early in life.
The Genetic and Developmental Basis of Jeune Syndrome
Primary Asphyxiating thoracic dystrophy (ATD) is generally recognized as an autosomal recessive skeletal ciliopathy linked to pathogenic variants in genes involved in ciliary function. These variants can disrupt skeletal development, although the detailed mechanism by which they produce different thoracic patterns remains incompletely understood. The specific causative variant is not identified in every patient. Secondary ATD is a separate condition that may develop after previous open chest wall deformity surgery.
These disturbances can affect the normal growth of the ribs and costal cartilages, resulting in abnormal thoracic morphology characterized by a narrowed chest, which may subsequently impact lung development and respiratory function.
The Impact and Clinical Manifestations
Children with Jeune syndrome have a narrow, abnormally shaped chest, which can make it difficult for their lungs to expand fully. The narrowed thoracic cage restricts lung expansion and may cause breathing difficulty and hypoxemia. Chronic pulmonary compression and inadequate lung expansion may also predispose patients to recurrent respiratory infections. Many infants show signs of oxygen deficiency at birth, and without treatment, the condition can be life-threatening.
Long-term effects include slow growth, short stature, and unevenly developed arms and legs. In addition to respiratory abnormalities, patients may also present with multisystem organ involvement, leading to complications such as renal failure or hepatic dysfunction. Because of these serious complications, ATD requires careful monitoring and medical intervention to improve outcomes.
Innovative Expansion Surgery at ICWS
Treating such a complex condition requires a specialized understanding of thoracic mechanics. The Institute of Chest Wall Surgery (ICWS) offers various treatment options for rare skeletal deformities. Its innovative chest wall expansion surgery is primarily used for Type I ATD, characterized by overall underdeveloped, small, and narrow rib cages.
For most Type II ATD patients, who often present with both anterior chest wall protrusion and bilateral chest wall depressions, a combination of the Wenlin procedure and the Wang procedure is typically required to improve overall chest shape and increase thoracic cavity space. In a few Type II patients who only exhibit isolated lateral chest wall depressions, the Wang procedure alone can achieve excellent corrective results.
Securing a Future for Thoracic Health
Although the detailed pathogenesis of primary ATD remains incompletely understood, it is recognized as an autosomal recessive genetic disorder, and its effects on thoracic development and respiratory function can be severe. For individuals with a narrowed thoracic cage and persistent respiratory or physical limitations, early evaluation and appropriate medical guidance are essential. With a clearer understanding of chest wall structure and available treatment options, appropriate management strategies can be guided toward improving breathing capacity and overall quality of life.